Author: Rachel Conroy
26 January, 2016
Read Rachel Conroy’s latest article published on the upcoming online blog and magazine Pharma und Marke (PuM). Here she examines the UKIPO’s decision, made late last year, in Glaxo Group Ltd versus Evonik Industries AG (Case O-587/15). This case, tackling the issue of likelihood of confusion, is of particular interest as the Hearing Officer takes note of the different consumers of pharmaceutical products and the effect this has on likelihood of confusion.
To read the article in full, click here.